Antimicrobial Resistance Guidances
- CVM GFI #106 The Use of Published Literature in Support of New Animal Drug Approvals
- CVM GFI #144 (VICH GL27) Pre-Approval Information for Registration of New Veterinary Medicinal Products for Food-Producing Animals with Respect to Antimicrobial Resistance
- CVM GFI #152 Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern
- CVM GFI #209 The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals
- FDA's Strategy on Antimicrobial Resistance - Questions and Answers
- CVM GFI #213 New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions with GFI #209
- CVM GFI #233 Veterinary Feed Directive Common Format Questions and Answers
- CVM GFI #252 Small Entity Compliance Guide Antimicrobial Animal Drug Sales and Distribution Reporting
- CVM GFI #261 - Eligibility Criteria for Expanded Conditional Approval of New Animal Drugs
- CVM GFI #263 - Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntarily Bring Under Veterinary Oversight All Products That Continue to be Available Over-the-Counter
- CVM GFI #273 Defining Durations of Use for Approved Medically Important Antimicrobial Drugs Fed to Food-Producing Animals